» Articles » PMID: 20797535

Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 2010 Aug 28
PMID 20797535
Citations 164
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by loss of motor neurons. With conformation-specific antibodies, we now demonstrate that misfolded mutant SOD1 binds directly to the voltage-dependent anion channel (VDAC1), an integral membrane protein imbedded in the outer mitochondrial membrane. This interaction is found on isolated spinal cord mitochondria and can be reconstituted with purified components in vitro. ADP passage through the outer membrane is diminished in spinal mitochondria from mutant SOD1-expressing ALS rats. Direct binding of mutant SOD1 to VDAC1 inhibits conductance of individual channels when reconstituted in a lipid bilayer. Reduction of VDAC1 activity with targeted gene disruption is shown to diminish survival by accelerating onset of fatal paralysis in mice expressing the ALS-causing mutation SOD1(G37R). Taken together, our results establish a direct link between misfolded mutant SOD1 and mitochondrial dysfunction in this form of inherited ALS.

Citing Articles

Hexokinase-I directly binds to a charged membrane-buried glutamate of mitochondrial VDAC1 and VDAC2.

Bieker S, Timme M, Woge N, Hassan D, Brown C, Marrink S Commun Biol. 2025; 8(1):212.

PMID: 39930004 PMC: 11811193. DOI: 10.1038/s42003-025-07551-9.


VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration.

Argueti-Ostrovsky S, Barel S, Kahn J, Israelson A Biomolecules. 2025; 15(1).

PMID: 39858428 PMC: 11762377. DOI: 10.3390/biom15010033.


Advancements in Targeting Ion Channels for the Treatment of Neurodegenerative Diseases.

Li Y, Fu J, Wang H Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598374 PMC: 11597607. DOI: 10.3390/ph17111462.


VDAC1-Based Peptides as Potential Modulators of VDAC1 Interactions with Its Partners and as a Therapeutic for Cancer, NASH, and Diabetes.

Shteinfer-Kuzmine A, Santhanam M, Shoshan-Barmatz V Biomolecules. 2024; 14(9).

PMID: 39334905 PMC: 11430116. DOI: 10.3390/biom14091139.


Unveiling the double-edged sword: SOD1 trimers possess tissue-selective toxicity and bind septin-7 in motor neuron-like cells.

Choi E, Hnath B, Sha C, Dokholyan N Structure. 2024; 32(10):1776-1792.e5.

PMID: 39208794 PMC: 11455619. DOI: 10.1016/j.str.2024.08.002.


References
1.
Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, Kasai N . Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci. 2001; 21(23):9246-54. PMC: 6763929. View

2.
Abu-Hamad S, Sivan S, Shoshan-Barmatz V . The expression level of the voltage-dependent anion channel controls life and death of the cell. Proc Natl Acad Sci U S A. 2006; 103(15):5787-92. PMC: 1458651. DOI: 10.1073/pnas.0600103103. View

3.
Rosen D, Siddique T, Patterson D, Figlewicz D, Sapp P, Hentati A . Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993; 362(6415):59-62. DOI: 10.1038/362059a0. View

4.
Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien J . Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci. 2005; 9(1):108-18. DOI: 10.1038/nn1603. View

5.
Cassina P, Cassina A, Pehar M, Castellanos R, Gandelman M, de Leon A . Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J Neurosci. 2008; 28(16):4115-22. PMC: 3844766. DOI: 10.1523/JNEUROSCI.5308-07.2008. View